Status:
COMPLETED
Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.
Lead Sponsor:
Rottapharm Spain
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the platelet antiaggregant effect that a chronic treatment with ASA (150 mg) produces,comparing this effect between two formulations of ASA: normal and the one...
Detailed Description
A large clinical trials have established the efficacy of the antiaggregant products in patients with ischemic cardiopathy, stroke and intermittent claudication. Without doubt, the acetylsalicylic aci...
Eligibility Criteria
Inclusion
- Previous episodes of myocardial infarction
- Previous episodes of instable angina pectoris
- Previous coronary revascularization
- Significant arterial coronary disease
Exclusion
- Patients with other pathologies that requires treatment with other antiaggregants
- Patients in treatment with low molecular weight heparin or oral anticoagulant
- Patients with antecedents of hypersensibility to ASA
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00425074
Start Date
January 1 2007
End Date
July 1 2007
Last Update
June 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Virgen de la Victoria
Málaga, Spain, 29010